Fragile X syndrome (FXS) results from deficiency of fragile X mental retardation protein (FMRP). FXS is the most common heritable form of mental retardation, and is associated with the occurrence of seizures. Factors responsible for initiating FXS-related hyperexcitability are poorly understood. Many protein-synthesis-dependent functions of group I metabotropic glutamate receptors (Gp1 mGluRs) are exaggerated in FXS. Gp1 mGluR activation can mobilize endocannabinoids (eCBs) in the hippocampus and thereby increase excitability, but whether FMRP affects eCBs is unknown. We studied Fmr1 knock-out (KO) mice lacking FMRP to test the hypothesis that eCB function is altered in FXS. Whole-cell evoked IPSCs (eIPSCs) and field potentials were recorded in the CA1 region of acute hippocampal slices. Three eCB-mediated responses were examined: depolarization-induced suppression of inhibition (DSI), mGluR-initiated eCBdependent inhibitory short-term depression (eCB-iSTD), and eCB-dependent inhibitory long-term depression (eCB-iLTD). Low concentrations of a Gp1 mGluR agonist produced larger eCB-mediated responses in Fmr1 KO mice than in wild-type (WT) mice, without affecting DSI. Western blots revealed that levels of mGluR1, mGluR5, or cannabinoid receptor (CB1R) were unchanged in Fmr1 KO animals, suggesting that the coupling between mGluR activation and eCB mobilization was enhanced by FMRP deletion. The increased susceptibility of Fmr1 KO slices to eCB-iLTD was physiologically relevant, since long-term potentiation of EPSP-spike (E-S) coupling induced by the mGluR agonist was markedly larger in Fmr1 KO mice than in WT animals. Alterations in eCB signaling could contribute to the cognitive dysfunction associated with FXS.
Introduction
Fragile X syndrome (FXS) is often accompanied by neuropsychiatric problems such as hyperactivity, autism, attention disorders, and seizures (de Vries et al., 1998; Jin and Warren, 2000) . FXS is typically caused by a trinucleotide repeat expansion on the X chromosome that causes epigenetic silencing of the Fmr1 gene and prevents expression of the encoded protein, fragile X mental retardation protein (FMRP). Knock-out of the Fmr1 gene in mice removes FMRP and mimics FXS in humans (O'Donnell and Warren, 2002) .
FMRP associates with translating polyribosomes and a subset of brain mRNAs, and negatively regulates protein synthesis (Feng et al., 1997; Brown et al., 2001) . Activation of group I metabotropic glutamate receptors (Gp1 mGluRs) leads to protein-synthesisdependent synaptic plasticity, where local synaptic control of protein synthesis is required for stable expression of long-term depression (LTD) (Weiler and Greenough, 1993; Merlin et al., 1998; Huber et al., 2000; Bear et al., 2004) . FMRP is synthesized in response to mGluR activation (Weiler and Greenough, 1999) . In Fmr1 knockout (KO) mice, Gp1 mGluR-dependent hippocampal LTD is enhanced (Huber et al., 2002) , probably because of alterations in local protein synthesis (Bear et al., 2004; Pfeiffer and Huber, 2006; Dölen et al., 2007) . Consistent with the "mGluR theory of fragile X" (Bear et al., 2004) , increased protein synthesis occurs with mGluR stimulation in the absence of FMRP (Chuang et al., 2005; Koekkoek et al., 2005; Hou et al., 2006) . As a consequence, a persistent, voltage-gated cation current becomes activated by Gp1 mGluRs, and accounts for prolonged epileptiform discharges in Fmr1 KO mice (Chuang et al., 2005; Bianchi et al., 2009) . Whether the initial tendency to hyperexcitability in FXS can be fully explained by this mechanism is unclear.
Activation of Gp1 mGluRs also mobilizes endocannabinoids (eCBs) (Maejima et al., 2001; Varma et al., 2001) , which activate CB1Rs on presynaptic cholecystokinin (CCK) interneuron terminals in hippocampus and suppress GABA release (Katona et al., 1999; Wilson et al., 2001) . ("Mobilization" refers to eCB synthesis and release, which cannot be distinguished in electrophysiological experiments.) In CA1, activation of Gp1 mGluRs induces both eCB-dependent inhibitory short-term depression (eCB-iSTD) and eCB-dependent inhibitory long-term depression (eCB-iLTD) at CCK cell synapses. Ca 2ϩ -dependent eCB mobilization [depolarization-induced suppression of inhibition (DSI)] (review by Alger, 2002) facilitates LTP induction at glutamatergic synapses (Carlson et al., 2002) , and eCB-iLTD underlies long-term changes of pyramidal cell excitability by increasing EPSPspike (E-S) coupling potentiation (Chevaleyre and Castillo, 2003) .
Despite intense study of the eCB system (Piomelli, 2003) , it is not known whether proteins downstream of mGluRs can influence eCB mobilization. The important role of mGluRs in both eCB and protein synthesis, together with evidence that certain cognitive deficits may result from disordered CB1-mediated signaling, suggests that FMRP deficiency could alter Gp1 mGluRdependent eCB mobilization. We have tested this hypothesis in mouse hippocampal slices and find that FMRP deficiency does not affect Ca 2ϩ -dependent release of eCB, or CB1Rs, but enhances the coupling between Gp1 mGluRs and eCB mobilization. The results may have significant implications for understanding both FXS and eCB signaling.
Materials and Methods
Animals. We used tissue from 2-to 4-month-old male Fmr1 KO and age-matched wild-type (WT) mice on the identical background strain, C57BL/6J (kindly provided by M. McKenna, University of Maryland, Baltimore, MD), and mGluR1 Ϫ/Ϫ (from F. Conquet, University of Lausanne, Lausanne, Switzerland) and mGluR5 Ϫ/Ϫ (from Jackson Laboratory) mice. To test the generality of the ( S)-3,5-dihydroxyphenylglycine (DHPG) sensitivity, in a number of experiments we also used 2-to 4-month-old mice (from Charles River) of the C57BL/6N (males), 129Sv (female), and CD1 (female) strains. Unless otherwise noted in the text, "WT" refers to C57BL/6J WT mice. All experimental protocols were reviewed and approved by the University of Maryland School of Medicine Institutional Animal Care and Use Committee, and all animal handling was conducted in accordance with national and international guidelines. The number of animals used was minimized, and all necessary precautions were taken to mitigate pain or suffering.
Preparation of slices. Mice were deeply sedated with isoflurane and decapitated. Slices, 400 m thick, were cut on a Vibratome (model VT1200s, Leica Microsystems) in an ice-cold extracellular recording solution. Slices were stored in a holding chamber on filter paper at the interface of this solution and a moist, oxygenated atmosphere at room temperature for Ն1 h before transfer to the recording chamber (RC-27L, Warner Instruments) and warmed to 30°C. The extracellular solution contained the following (in mM): 120 NaCl, 3 KCl, 2.5 CaCl 2 , 2 MgSO 4 , 1 NaH 2 PO 4 , 25 NaHCO 3 , and 20 glucose, and was bubbled with 95% O 2 , 5% CO 2 , pH 7.4.
Electrophysiology. Whole-cell pipettes were pulled from thin wall glass capillaries (1.5 O.D., World Precision Instruments). Electrode resistances in the bath were 3-6 M⍀ with internal solution containing the following (in mM): 90 CsCH 3 SO 4 , 1 MgCl 2 , 50 CsCl, 2 MgATP, 0.2 Cs 4 -BAPTA, 10 HEPES, 0.3 Tris GTP, and 5 QX314. If the series resistances changed by Ͼ20%, the data were discarded. Data were collected with an Axopatch 1C amplifier (Molecular Devices), filtered at 1 kHz, and digitized at 5 kHz using a Digidata 1200 (Molecular Devices) and Clampex 8 software (Molecular Devices). 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX) (10 M) and D-AP5 (20 M) were present in all whole-cell experiments to block glutamatergic EPSCs. Monosynaptic evoked IPSCs (eIPSCs) were elicited by 100-s-long extracellular stimuli delivered at 0.25 Hz with concentric bipolar stimulating electrodes placed in stratum radiatum (s. radiatum).
Slices were pretreated with -agatoxin GVIA (agatoxin, 300 nM) to reduce the contribution of eCB-insensitive eIPSCs (Lenz et al., 1998; Wilson et al., 2001 ). Stimulation in s. radiatum elicited eIPSCs every 4 s, and at 90 s intervals, the pyramidal cell was depolarized to 0 mV for 1 s to open voltage-gated calcium channels, increase [Ca 2ϩ ] i , and induce DSI. The magnitude of DSI was calculated as follows: [(eIPSC C Ϫ eIPSC T )/ eIPSC C ] ϫ 100%, where eIPSC C is the mean amplitude of 8 eIPSCs before depolarization and eIPSC T is the mean amplitude of 3 eIPSCs after depolarization. The "DSI integral" (e.g., Fig. 2 D) was calculated as the percentage of eIPSC reduction (assumed constant during each 4 s time bin between stimuli) summed across all bins from time 0 (the end of the DSI step) until 90 s after the step.
For field potential recording, stimuli were delivered at 0.05 Hz, and NBQX and D-AP5 were omitted. Field pipettes were filled with extracellular solution and placed in CA1 s. pyramidale to record both field EPSPs (fEPSPs) and population spikes (PSs). The stimulation strength was adjusted to produce PS amplitudes 30 -40% of maximal. The E-S coupling magnitude was calculated as PS amplitude/fEPSP slope and expressed as percentage of the baseline value.
Western blot. Hippocampi were quickly removed after decapitation and homogenized in RIPA buffer (Tris, NaCl, H 2 O, Igepal CA630, deoxycholic acid, EDTA, protease inhibitor, and phosphatase inhibitor).
Homogenates were centrifuged at 9000 ϫ g for 30 min at 4°C. Protein concentrations of supernatants were determined using the Bradford method with bovine serum albumin as standard. Samples (10 g/l) were denatured by heat, run on an SDS-PAGE gel (4 -12% Bis-Tris; Invitrogen), and transferred onto PVDF membranes (Invitrogen). Membranes were washed in T-TBS, blocked in 5% or 10% milk for 1 h, and probed with a rabbit anti-CB1R (1:1000, Calbiochem, EMD4Biosciences), a rabbit anti-mGluR5 (1:5000, Millipore Biotechnology), or a rabbit anti-mGluR1 (1:1000, Millipore Biotechnology) polyclonal antibody overnight at 4°C. They were then washed 3ϫ in T-TBS, exposed to HRP-conjugated anti-rabbit IgG (1:3000) for 30 min, and washed and developed using a chemiluminescent detection system. Finally, the membranes were stripped with stripping buffer (Thermo Scientific, Fisher Scientific) for 20 min, blocked again, and reprobed with a rabbit anti-␤-actin (1:3000, Cell Signaling Technologies) polyclonal antibody as a loading control. Densitometry values from the samples were acquired using NIH Image and were normalized to their respective ␤-actin values.
Chemicals. Except for the CB1R antagonist, N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1 H-pyrazole-3-carboxamide hydrochloride (SR141716A), all drugs were made up as 1000ϫ stocks in distilled water, divided into 20 l aliquots, and frozen at Ϫ20°C until use. SR141716A was made up in DMSO; final DMSO concentration in the bath was 0.02%. Once thawed, aliquots were either used or discarded within 2 months after preparation; none were refrozen and reused. Drugs were obtained from Tocris Bioscience tions, we used the Kolmogorov-Smirnov (K-S) test, available at http://www.physics.csbsju.edu/stats/KS-test.n.plot_form.html.
Results
mGluRs mobilize eCBs in Fmr1 KO mice more effectively than in C57BL/6J WT mice To determine whether mGluR-dependent eCB-iSTD is different in CA1 pyramidal neurons from Fmr1 KO and WT mice, both C57BL/6J, we bath applied the selective Gp1 agonist, DHPG, at concentrations from 1 to 50 M for 3-4 min (Fig. 1 A) . At doses of Ͼ2 M, DHPG reduced eIPSCs in both WT and Fmr1 KO mice. The responses were similar at the highest doses; however, at intermediate concentrations, DHPG suppressed eIPSCs more effectively in Fmr1 KO mice. In WT mice, 5, 10, and 20 M DHPG reduced eIPSC amplitudes to 81.6 Ϯ 3.9%, 72.5 Ϯ 3.4%, and 45.7 Ϯ 7.6% of control, respectively. In Fmr1 KO mice, the same doses reduced eIPSC amplitudes to 70.2 Ϯ 5.5%, 45.2 Ϯ 4.6%, and 36.3 Ϯ 4.2% of control, respectively. At 50 M, DHPG reduced eIPSC similarly in both strains (to 31.4 Ϯ 7.1% of control, WT, n ϭ 7 and to 29.8 Ϯ 4.4% of control, Fmr1 KO, n ϭ 6). The group data, fit with sigmoidal curves, suggest that the doseresponse relationship is shifted to the left in Fmr1 KO mice (Fig.  1 B) . The largest difference was apparent at 10 M DHPG, as shown by cumulative probability distributions of the eIPSC suppressions (K-S test, p Ͻ 0.01) (Fig. 1C) . Hence, 10 M DHPG was used in subsequent experiments, except as noted. The Gp1 antagonists, MPEP (10 M) plus YM298198 (4 M) for Ͼ1 h, prevented DHPG from suppressing eIPSC amplitudes (Fig. 1 B, gray triangle) (n ϭ 4), showing that the DHPG effects are Gp1 mGluR dependent. Finally, the CB1R antagonist, SR141716A, 5 M (slices pretreated for Ͼ2 h and SR141716A continuously bath applied), prevented the effects of DHPG in Fmr1 KO slices (n ϭ 7). Thus, DHPG suppresses eIPSCs by activating Gp1 mGluRs and mobilizing eCBs in Fmr1 KO mice. Ϫ/Ϫ (n ϭ 2), and Fmr1 KO (n ϭ 6) mice. F, mGluR1 from WT (n ϭ 5), mGluR1 Ϫ/Ϫ (n ϭ 3), and Fmr1 KO (n ϭ 4) mice. G, CB1R from WT (n ϭ 4) and Fmr1 KO (n ϭ 4) mice. Fmr1 KO mice seem to have heightened responsiveness to DHPG, but alternatively, C57BL/6J WT mice might have abnormally low responsiveness that is absent in the KO. To test this possibility, we applied 10 M DHPG to pyramidal cells in slices from WT C57BL/6N male mice, or female WT 129-Sv or CD1 mice. DHPG-induced eIPSC suppressions among all WT mice were indistinguishable, and significantly smaller than responses of the KO mice (supplemental Fig. 1 , available at www.jneurosci. org as supplemental material). The time to peak (t 1/2 ) of the eIPSC suppression was not significantly different among the strains (supplemental Fig. 2 , available at www.jneurosci.org as supplemental material), showing that DHPG does not have better tissue access in Fmr1 KO mice.
DSI did not differ between Fmr1 KO and WT mice
To test for eCB system differences, we compared the transient, Ca 2ϩ -induced, eCB-mediated reduction of eIPSCs, DSI, in hippocampal CA1 pyramidal neurons from Fmr1 KO and WT mice. DSI reduced eIPSCs in both WT (n ϭ 69) and Fmr1 KO (n ϭ 51) mice (Fig. 2 A, B) . Recovery from DSI was determined by fitting a single-exponential decay function from the peak suppression back to baseline (Fig. 2C) (n ϭ 24) , and as a final check on the Ca 2ϩ -dependent eCB release process, we also calculated the "DSI integral," which includes information of both peak and duration of the eCB effects (see Materials and Methods). The DSI decay time constants and integrals were essentially identical in both groups. Neither t tests nor K-S tests revealed a significant difference between Fmr1 KO and WT mice for DSI magnitude, decay, or integral values. Therefore, deletion of FMRP does not affect any of the following: (1) CB1R, (2) eCB release from pyramidal cells, or (3) the coupling between the rise in postsynaptic [Ca 2ϩ ] i and eCB mobilization.
Protein expression of mGluR1, mGluR5, or CB1R is unchanged in Fmr1 KO mice Several mechanisms could underlie the increased ability of mGluRs to induce eCBmediated responses in Fmr1 KO mice, including enhanced CB1R expression or downstream effectors, or increases in mGluR1, mGluR5, or coupling between mGluRs and eCB mobilization. Western blot analyses revealed no differences between Fmr1 KO and WT mice in expression of any of these receptors (Fig. 2E-G) . Hence, increased receptor number does not explain the increased sensitivity to DHPG in Fmr1 KO mice; rather, coupling between the mGluRs and eCB mobilization could be responsible.
mGluR-dependent eCB-iLTD is enhanced in Fmr1 KO mice
Prolonged activation (ϳ10 min) of Gp1 mGluRs with 50 M DHPG produces eCB-iLTD (Chevaleyre and Castillo, 2003; Edwards et al., 2006) ; lower DHPG concentrations generally do not. If coupling between mGluRs and eCB mobilization is enhanced in Fmr1 KO mice, then lower DHPG concentrations might be able to induce eCB-iLTD in these mice. To test this prediction, we applied 10 M DHPG to slices of both Fmr1 KO and WT mice for 10 min. The eIPSCs were suppressed to 62.1 Ϯ 4.6% of baseline in WT mice and 36.3 Ϯ 3.9% of baseline in Fmr1 KO mice during DHPG application (Fig. 3 A, B) ( p Ͻ 0.01). However, 20 min after washout of DHPG, the eIPSCs returned to baseline (n ϭ 4) in WT mice, but remained depressed (n ϭ 5, p Ͻ 0.01) (Fig. 3B) in Fmr1 KO mice. and Fmr1 KO (n ϭ 7) mice (Fig. 4 A1 , typical traces in Fig. 4 B) . However, 10 M DHPG applied for 10 min induced strong E-S coupling potentiation in Fmr1 KO (Fig. 4 A2 ) (n ϭ 6) but only a slight effect in WT (n ϭ 7) mice ( p Ͻ 0.05). SR141716A prevented E-S coupling potentiation in both groups (Fig. 4 A3) (n ϭ 6, Fmr1 KO; n ϭ 5, WT).
CB1R-dependent E-S coupling potentiation is enhanced in

Discussion
Our results reveal that FMRP deficiency in C57BL/6J mice leads to increased neuronal excitability mediated by eCBs. The ability of Gp1 mGluRs to mobilize eCBs is heightened in Fmr1 KO animals, resulting in more pronounced eCB-iSTD, as well as greater susceptibility to eCB-iLTD, and E-S coupling potentiation. By altering mechanisms of synaptic plasticity, these factors could contribute to the cognitive dysfunctions associated with FXS. eCBs are mobilized by two kinds of cellular stimulation: a strong rise in [Ca 2ϩ ] i or activation of certain G-protein-coupled receptors, such as Gp1 mGluRs (Maejima et al., 2001; Varma et al., 2001) . Activation of Gp1 mGluRs stimulates local translation of synaptic mRNAs (Weiler and Greenough, 1993; Merlin et al., 1998; Huber et al., 2000; Bear et al., 2004) , including the mRNA that encodes FMRP (Weiler and Greenough, 1999) . Our data suggest that FMRP is involved in regulating mGluRdependent mobilization of eCB. Similarities in magnitude and duration of DSI in Fmr1 KO and WT mice suggested that FMRP did not affect Ca 2ϩ -induced mobilization of eCBs, CB1Rs, or the effector mechanisms that inhibit GABA release downstream of CB1R. Maximal responses produced by DHPG were unaffected by FMRP deficiency, implying that the coupling between mGluRs and eCB mobilization may be quantitatively, but not qualitatively, altered. Data from Western blots of mGluRs and CB1Rs, together with the increased capacity of moderate concentrations of DHPG to initiate eCB-dependent responses, support the conclusion that the coupling between mGluRs and eCB mobilization is modulated by FMRP.
The mechanism of FMRP modulation of eCB mobilization cannot be determined without more information on the pathway between mGluRs and the signaling pool of eCBs (probably 2-AG) (e.g., Hashimotodani et al., 2005) . eCBs are derived directly from membrane lipids (Piomelli, 2003) , and it is unlikely that FMRP is immediately involved in this process. Nevertheless, cellular proteins regulated by FMRP may play some role. Diacylglycerol lipase meditates 2-AG synthesis (Piomelli, 2003) , and gene knock-out experiments show that PLC ␤1 is upstream of eCB mobilization in the hippocampus (Hashimotodani et al., 2005) , although obligatory activation PLC ␤1 before brief, phasic release of eCBs has not been demonstrated (Hashimotodani et al., 2005; Edwards et al., 2008) . A presently uncharacterized transporter participates in eCB release in some circumstances (Adermark and Lovinger, 2007; Edwards et al., 2008) , and might constitute another potential target for FMRP regulation. Understanding the connections between FMRP and eCB mobilization will be an important goal of future studies.
Bear and colleagues (Bear et al., 2004; Dölen et al., 2007) have put forward an "mGluR theory of fragile X mental retardation," which holds that dysfunction of Gp1 mGluR effector mechanisms stemming from FMRP deficiency may cooperate in shaping the FXS phenotype. Because eCB mobilization is downstream of these mGluRs, our study effectively tested a prediction of the theory, and our results are broadly consistent with it. Importantly, though less obviously, our data may also help account for some poorly understood details of FXS-related phenomena. For instance, enhancement of eCB-iLTD (Fig. 3) could foster the "hyperplasticity" represented by enhanced LTD in the CA1 (Huber et al., 2002) . Approximately 25% of FXS patients suffer from epilepsy during development (Sabaratnam et al., 2001) , and seizure activity is often increased by suppression of GABA inhibition. Prolonged epileptiform discharges can be mediated by altered activation of Gp1 mGluRs in Fmr1 KO mice (Chuang et al., 2005; Bianchi et al., 2009) ; however, in these experiments bicuculline is usually used to block GABA responses and induce epileptiform discharges. Perhaps the disinhibition represented by eCB-iLTD contributes to initial changes of pyramidal cell excitability, and thus sets the stage for the prolonged seizure states. The endocannabinoid system could represent another target for intervention in the treatment of FXS.
